These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14748795)

  • 41. Quality assurance in breast cancer screening cytology: a review of the literature and a report on the U.K. national cytology scheme.
    Wells CA
    Eur J Cancer; 1995; 31A(2):273-80. PubMed ID: 7718337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.
    Bevers TB; Anderson BO; Bonaccio E; Buys S; Daly MB; Dempsey PJ; Farrar WB; Fleming I; Garber JE; Harris RE; Heerdt AS; Helvie M; Huff JG; Khakpour N; Khan SA; Krontiras H; Lyman G; Rafferty E; Shaw S; Smith ML; Tsangaris TN; Williams C; Yankeelov T;
    J Natl Compr Canc Netw; 2009 Nov; 7(10):1060-96. PubMed ID: 19930975
    [No Abstract]   [Full Text] [Related]  

  • 43. Spindle Cell Lesions of the Breast on Fine-Needle Aspiration Biopsy: A Miscellany of Masses.
    Michelow P; Field AS
    Acta Cytol; 2019; 63(4):328-339. PubMed ID: 31117069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytology of indeterminate cases (C3). Can this diagnostic class be improved?
    Fiaccavento S; Simone G
    Pathologica; 2010 Oct; 102(5):409-13. PubMed ID: 21361122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].
    Bak M; Péter I; Nyári T; Simon P; Újlaky M; Boér A; Kásler M
    Orv Hetil; 2015 Oct; 156(41):1661-6. PubMed ID: 26551169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Retrospective results of ultrasonographically-guided biopsy the breast cancer screening program of the Ariana area of Tunisia].
    Salem A; Debabria H; Mehiri S; Driss M; Kribi L; Sellemi M; Mrad K; Hamza R; Mnif N; Ben Romdhane K; Zaanouni E; Gueddana N
    Tunis Med; 2009 Jul; 87(7):463-70. PubMed ID: 20063681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interpretation of fine needle aspiration cytology of the breast: a comparison of cytological, frozen section, and final histological diagnoses.
    Bofin AM; Lydersen S; Isaksen C; Hagmar BM
    Cytopathology; 2004 Dec; 15(6):297-304. PubMed ID: 15606361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abolish C3.
    Trott PA
    Cytopathology; 2003 Aug; 14(4):183-4. PubMed ID: 12873308
    [No Abstract]   [Full Text] [Related]  

  • 49. The West Midlands breast cancer screening status algorithm - methodology and use as an audit tool.
    Lawrence G; Kearins O; O'Sullivan E; Tappenden N; Wallis M; Walton J
    J Med Screen; 2005; 12(4):179-84. PubMed ID: 16417694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality of diagnosis and surgical management of breast lesions in a community hospital: room for improvement?
    Hanley C; Kessaram R
    Can J Surg; 2006 Jun; 49(3):185-92. PubMed ID: 16749979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison between fine needle aspiration cytology with histopathology to validate accurate diagnosis of palpable breast lump.
    Saleh FM; Ansari NP; Alam O
    Mymensingh Med J; 2012 Jul; 21(3):450-5. PubMed ID: 22828542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The abnormal mammogram in clinically normal breasts: a challenge for surgeons.
    Deschênes L
    Can J Surg; 1995 Apr; 38(2):110-1. PubMed ID: 7728662
    [No Abstract]   [Full Text] [Related]  

  • 53. International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology: A Review of Predictive Values and Risks of Malignancy.
    Hoda RS; Brachtel EF
    Acta Cytol; 2019; 63(4):292-301. PubMed ID: 31141809
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regarding trends in recall, biopsy, and positive biopsy rates for screening mammography.
    Ellis RL
    Radiology; 2006 Jan; 238(1):375-6; author reply 376. PubMed ID: 16373783
    [No Abstract]   [Full Text] [Related]  

  • 55. [An evaluation of effectiveness of cytological method in diagnostics of breast tumors].
    Vladimirova AV; Novik VI; Krasilnikova LA; Lindeberg TY; Nefedova AV; Yakubo EL
    Vopr Onkol; 2015; 61(4):614-8. PubMed ID: 26571832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fine-needle aspiration cytology vs. core biopsy in the diagnosis of breast lesions.
    Berner A; Davidson B; Sigstad E; Risberg B
    Diagn Cytopathol; 2003 Dec; 29(6):344-8. PubMed ID: 14648793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Breast cancer screening. In search of more quality].
    Wegner A
    MMW Fortschr Med; 2001 Jun; 143(23):12. PubMed ID: 11460411
    [No Abstract]   [Full Text] [Related]  

  • 58. Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates.
    Goldzweig CL; Parkerton PH; Washington DL; Lanto AB; Yano EM
    Am J Manag Care; 2004 Apr; 10(4):265-72. PubMed ID: 15124503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Masood's and Modified Masood's Scoring Index: An Evaluation of Fine Needle Aspiration Cytology of Breast Lesions with Histopathological Correlation.
    Agarwal C; Chauhan V; Pujani M; Singh K; Raychaudhari S; Singh M
    Acta Cytol; 2019; 63(3):233-239. PubMed ID: 30759436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Palpable breast masses with probably benign morphology at sonography: can biopsy be deferred?
    Park YM; Kim EK; Lee JH; Ryu JH; Han SS; Choi SJ; Lee SJ; Yoon HK
    Acta Radiol; 2008 Dec; 49(10):1104-11. PubMed ID: 18855166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.